Loading
Latest filing published 01 Jun 2026 for Telix Pharmaceuticals Limited, €6.
No signal scores available.
Maria Rivas appears in our data through filings on Telix Pharmaceuticals Limited shares, published by ASX. In total, 2 filings cover trades dated from 13 May 2026 to 26 May 2026.
No open-market purchase appears, only 1 sale worth €6.
The latest filing, published on 1 June 2026, reports an open-market sale of €6 in Telix Pharmaceuticals Limited. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from ASX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations